SK18197A3 - Combinated preparation and a pharmaceutical composition containing its, useful for the treatment of infection by hiv - Google Patents

Combinated preparation and a pharmaceutical composition containing its, useful for the treatment of infection by hiv Download PDF

Info

Publication number
SK18197A3
SK18197A3 SK181-97A SK18197A SK18197A3 SK 18197 A3 SK18197 A3 SK 18197A3 SK 18197 A SK18197 A SK 18197A SK 18197 A3 SK18197 A3 SK 18197A3
Authority
SK
Slovakia
Prior art keywords
compound
hiv
combination
day
dose
Prior art date
Application number
SK181-97A
Other languages
English (en)
Slovak (sk)
Inventor
Paul J Deutsch
Emilio A Emini
Joseph P Vacca
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SK18197A3 publication Critical patent/SK18197A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK181-97A 1994-08-11 1995-08-07 Combinated preparation and a pharmaceutical composition containing its, useful for the treatment of infection by hiv SK18197A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28947494A 1994-08-11 1994-08-11
US33936994A 1994-11-14 1994-11-14
US49246195A 1995-07-20 1995-07-20
PCT/US1995/009956 WO1996004913A1 (en) 1994-08-11 1995-08-07 Hiv protease inhibitor combination

Publications (1)

Publication Number Publication Date
SK18197A3 true SK18197A3 (en) 1997-09-10

Family

ID=27403895

Family Applications (1)

Application Number Title Priority Date Filing Date
SK181-97A SK18197A3 (en) 1994-08-11 1995-08-07 Combinated preparation and a pharmaceutical composition containing its, useful for the treatment of infection by hiv

Country Status (19)

Country Link
EP (1) EP0774969B8 (pl)
JP (1) JPH10504036A (pl)
KR (1) KR970704441A (pl)
CN (1) CN1101190C (pl)
AT (1) ATE232727T1 (pl)
AU (1) AU698664B2 (pl)
CA (1) CA2197207C (pl)
CY (1) CY2360B1 (pl)
CZ (1) CZ292577B6 (pl)
DE (1) DE69529678T2 (pl)
DK (1) DK0774969T3 (pl)
ES (1) ES2190456T3 (pl)
HU (1) HUT76540A (pl)
IL (1) IL114808A (pl)
MX (1) MX9701121A (pl)
NO (1) NO314168B1 (pl)
PL (1) PL181578B1 (pl)
SK (1) SK18197A3 (pl)
WO (1) WO1996004913A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
CA2270546A1 (en) * 1996-11-08 1998-05-22 Japan Energy Corporation Aids remedy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US517041A (en) * 1894-03-27 Fruit-picker
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2096408C (en) * 1990-11-19 2005-02-08 Gary Anthony Decrescenzo Retroviral protease inhibitors
DK0558657T3 (da) * 1990-11-19 1997-07-07 Monsanto Co Retrovirale proteaseinhibitorer
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
EP1302468B1 (en) * 1992-12-29 2008-12-17 Abbott Laboratories Processes and intermediates for manufacturing retroviral protease inhibiting compounds

Also Published As

Publication number Publication date
NO970632L (no) 1997-04-10
CA2197207A1 (en) 1996-02-22
ATE232727T1 (de) 2003-03-15
CA2197207C (en) 2006-10-17
NO970632D0 (no) 1997-02-11
DE69529678T2 (de) 2003-09-25
HUT76540A (en) 1997-09-29
EP0774969B1 (en) 2003-02-19
PL318506A1 (en) 1997-06-23
AU698664B2 (en) 1998-11-05
AU3361195A (en) 1996-03-07
IL114808A (en) 1999-10-28
CN1101190C (zh) 2003-02-12
CZ292577B6 (cs) 2003-10-15
JPH10504036A (ja) 1998-04-14
EP0774969B8 (en) 2003-07-02
MX9701121A (es) 1997-05-31
EP0774969A1 (en) 1997-05-28
DE69529678D1 (de) 2003-03-27
KR970704441A (ko) 1997-09-06
IL114808A0 (en) 1995-12-08
NO314168B1 (no) 2003-02-10
PL181578B1 (pl) 2001-08-31
CN1160350A (zh) 1997-09-24
ES2190456T3 (es) 2003-08-01
WO1996004913A1 (en) 1996-02-22
CY2360B1 (en) 2004-06-04
CZ38997A3 (en) 1997-11-12
DK0774969T3 (da) 2003-03-31

Similar Documents

Publication Publication Date Title
US5578597A (en) Combination therapy for HIV infection
US6689761B1 (en) Combination therapy for HIV infection
US6180634B1 (en) Combination therapy for the treatment of AIDS
SK18197A3 (en) Combinated preparation and a pharmaceutical composition containing its, useful for the treatment of infection by hiv
HUT76546A (en) Combinative pharmaceutical compositions and therapy for treating hiv infection
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
RU2194506C2 (ru) Сочетание ингибиторов вич-протеазы
HK1004659B (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
CN1118142A (zh) 逆转录病毒抑制剂组合物
CZ20001752A3 (cs) Farmaceutické prostředky obsahující kombinaci pro léčbu AIDS